Jenburkt Pharmaceuticals Limited (JENBURPH.BO)
INR 1285.0
(-2.26%)
INR 1285.0
(-2.26%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 85.61 Million INR | 2.69% |
| 2022 | 83.37 Million INR | -15.68% |
| 2021 | 98.87 Million INR | 30.42% |
| 2020 | 75.81 Million INR | -30.44% |
| 2019 | 108.98 Million INR | 10.86% |
| 2018 | 98.31 Million INR | 44.48% |
| 2017 | 68.04 Million INR | -36.68% |
| 2016 | 107.45 Million INR | 30.43% |
| 2015 | 82.38 Million INR | 8.68% |
| 2014 | 75.8 Million INR | 16.56% |
| 2013 | 65.03 Million INR | -15.72% |
| 2012 | 77.16 Million INR | 22.91% |
| 2011 | 62.77 Million INR | 8.21% |
| 2010 | 58.01 Million INR | 5.91% |
| 2009 | 54.77 Million INR | -22.24% |
| 2008 | 70.43 Million INR | 2.94% |
| 2007 | 68.42 Million INR | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | - INR | -100.0% |
| 2023 FY | 85.61 Million INR | 2.69% |
| 2023 Q4 | 85.61 Million INR | 0.0% |
| 2023 Q3 | - INR | -100.0% |
| 2023 Q2 | 97.09 Million INR | 0.0% |
| 2023 Q1 | - INR | -100.0% |
| 2022 Q3 | - INR | -100.0% |
| 2022 Q2 | 114.6 Million INR | 0.0% |
| 2022 Q1 | - INR | -100.0% |
| 2022 Q4 | 83.37 Million INR | 0.0% |
| 2022 FY | 83.37 Million INR | -15.68% |
| 2021 Q4 | 98.87 Million INR | 0.0% |
| 2021 Q2 | 79.26 Million INR | 0.0% |
| 2021 FY | 98.87 Million INR | 30.42% |
| 2021 Q1 | - INR | -100.0% |
| 2021 Q3 | - INR | -100.0% |
| 2020 Q4 | 75.81 Million INR | 0.0% |
| 2020 Q3 | - INR | -100.0% |
| 2020 FY | 75.81 Million INR | -30.44% |
| 2020 Q1 | - INR | -100.0% |
| 2020 Q2 | 131.32 Million INR | 0.0% |
| 2019 FY | 108.98 Million INR | 10.86% |
| 2019 Q4 | 108.98 Million INR | 0.0% |
| 2019 Q3 | - INR | -100.0% |
| 2019 Q1 | - INR | -100.0% |
| 2019 Q2 | 114.62 Million INR | 0.0% |
| 2018 Q3 | - INR | -100.0% |
| 2018 FY | 98.31 Million INR | 44.48% |
| 2018 Q4 | 98.31 Million INR | 0.0% |
| 2018 Q2 | 80.63 Million INR | 0.0% |
| 2018 Q1 | - INR | -100.0% |
| 2017 Q1 | - INR | -100.0% |
| 2017 Q3 | - INR | -100.0% |
| 2017 Q4 | 68.04 Million INR | 0.0% |
| 2017 Q2 | 68.51 Million INR | 0.0% |
| 2017 FY | 68.04 Million INR | -36.68% |
| 2016 Q2 | 62.22 Million INR | 0.0% |
| 2016 FY | 107.45 Million INR | 30.43% |
| 2016 Q1 | - INR | -100.0% |
| 2016 Q4 | 107.45 Million INR | 0.0% |
| 2016 Q3 | - INR | -100.0% |
| 2015 Q2 | 83.23 Million INR | 0.0% |
| 2015 FY | 82.38 Million INR | 8.68% |
| 2015 Q4 | 82.38 Million INR | 0.0% |
| 2015 Q3 | - INR | -100.0% |
| 2015 Q1 | - INR | -100.0% |
| 2014 Q2 | 71.1 Million INR | 0.0% |
| 2014 Q1 | - INR | -100.0% |
| 2014 FY | 75.8 Million INR | 16.56% |
| 2014 Q4 | 75.8 Million INR | 0.0% |
| 2014 Q3 | - INR | -100.0% |
| 2013 Q4 | 65.03 Million INR | 0.0% |
| 2013 Q2 | 58.71 Million INR | 0.0% |
| 2013 Q1 | - INR | -100.0% |
| 2013 FY | 65.03 Million INR | -15.72% |
| 2013 Q3 | - INR | -100.0% |
| 2012 FY | 77.16 Million INR | 22.91% |
| 2012 Q4 | 77.16 Million INR | 0.0% |
| 2011 Q4 | 62.77 Million INR | 0.0% |
| 2011 FY | 62.77 Million INR | 8.21% |
| 2010 FY | 58.01 Million INR | 5.91% |
| 2009 FY | 54.77 Million INR | -22.24% |
| 2008 FY | 70.43 Million INR | 2.94% |
| 2007 FY | 68.42 Million INR | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Hindustan Bio Sciences Limited | - INR | -Infinity% |
| KIMIA BIOSCIENCES LIMITED | 308.03 Million INR | 72.205% |
| SHELTER PHARMA LIMITED | 99.29 Million INR | 13.771% |
| Vasundhara Rasayans Limited | 17.34 Million INR | -393.697% |
| Sunil Healthcare Limited | 140.54 Million INR | 39.081% |
| Chemo Pharma Laboratories Limited | - INR | -Infinity% |
| MedPlus Health Services Limited | 13.4 Billion INR | 99.361% |
| Bharat Immunologicals & Biologicals Corporation Limited | 14.22 Million INR | -502.046% |
| Patidar Buildcon Limited | 12.6 Million INR | -579.23% |
| Roopa Industries Limited | 251.62 Million INR | 65.974% |
| Smruthi Organics Limited | 297.76 Million INR | 71.247% |
| Trident Lifeline Limited | 125.84 Million INR | 31.964% |
| PANJON LTD. | 37.42 Million INR | -128.8% |
| Pharmaids Pharmaceuticals Limited | 35.91 Million INR | -138.394% |
| Gujarat Terce Laboratories Limited | 39.84 Million INR | -114.854% |
| TIAAN CONSUMER LIMITED | 37.1 Million INR | -130.755% |
| Anuh Pharma Limited | 754 Million INR | 88.645% |
| Crestchem Limited | - INR | -Infinity% |
| Emmessar Biotech & Nutrition Limited | 891 Thousand INR | -9509.091% |
| Sandu Pharmaceuticals Limited | 122.5 Million INR | 30.112% |
| Tyche Industries Limited | 125.56 Million INR | 31.813% |
| Fredun Pharmaceuticals Limited | 1.78 Billion INR | 95.201% |
| Trimurthi Limited | 11.94 Million INR | -616.79% |
| Shukra Pharmaceuticals Limited | 23.14 Million INR | -269.932% |
| Norris Medicines Limited | 43.33 Million INR | -97.567% |
| Zenlabs Ethica Limited | 119.95 Million INR | 28.623% |
| Vikram Thermo (India) Limited | 146.62 Million INR | 41.609% |
| ANG Lifesciences India Limited | 477.65 Million INR | 82.076% |
| Parmax Pharma Limited | 43.06 Million INR | -98.827% |
| Veerhealth Care Limited | 13.96 Million INR | -513.302% |
| Deccan Health Care Limited | 456.96 Million INR | 81.264% |
| SUDARSHAN PHARMA INDUSTRIES LI | 857.41 Million INR | 90.015% |
| Makers Laboratories Limited | 338.04 Million INR | 74.673% |
| Lactose (India) Limited | 167.93 Million INR | 49.017% |
| OXYGENTA PHARMACEUTICAL LIMITE | 137.16 Million INR | 37.581% |
| Zenith Healthcare Limited | 19.76 Million INR | -333.131% |
| Sanjivani Paranteral Limited. | 97.33 Million INR | 12.035% |
| Bacil Pharma Limited | -45.66 Thousand INR | 187609.855% |
| PRAVEG LIMITED | 120.99 Million INR | 29.238% |
| Denis Chem Lab Limited | 101.89 Million INR | 15.977% |
| Kwality Pharmaceuticals Limited | 783.87 Million INR | 89.078% |
| Colinz Laboratories Limited | 8.46 Million INR | -910.946% |
| Godavari Drugs Limited | 206.5 Million INR | 58.54% |
| SHAMROCK INDUSTRIAL CO.LTD. | -7.1 Million INR | 1304.516% |
| Zenotech Laboratories Limited | 8.4 Million INR | -919.007% |
| Panchsheel Organics Limited | 395.22 Million INR | 78.337% |
| Shree Ganesh Remedies Limited | 249.88 Million INR | 65.737% |
| Vivanza Biosciences Limited | 20.06 Million INR | -326.741% |
| Phaarmasia Limited | 85 Million INR | -0.725% |
| Sastasundar Ventures Limited | 1.15 Billion INR | 92.606% |
| Medi-Caps Limited | 57.35 Million INR | -49.265% |
| DECIPHER LABS LIMITED | - INR | -Infinity% |
| Gujarat Themis Biosyn Limited | 33.26 Million INR | -157.355% |
| Ambalal Sarabhai Enterprises Limited | 161.76 Million INR | 47.074% |
| Mercury Laboratories Limited | 62.06 Million INR | -37.945% |
| Gennex Laboratories Limited | 251.75 Million INR | 65.991% |
| BDH Industries Limited | 50.02 Million INR | -71.162% |
| Coral Laboratories Limited | 151.56 Million INR | 43.512% |
| Concord Drugs Limited | 229.23 Million INR | 62.65% |
| Bharat Parenterals Limited | 614.67 Million INR | 86.071% |
| Beryl Drugs Limited | 12.6 Million INR | -579.392% |
| Vista Pharmaceuticals Limited | 67.86 Million INR | -26.165% |
| Evoq Remedies Limited | 31.25 Million INR | -173.974% |
| Add-Shop E-Retail Limited | 257.94 Million INR | 66.807% |
| Transchem Limited | 1.00 INR | -8561699900.0% |
| Ishita Drugs and Industries Limited | 10.64 Million INR | -704.52% |
| Parnax Lab Limited | 299.27 Million INR | 71.392% |
| Source Natural Foods and Herbal Supplements Limited | 43.01 Million INR | -99.058% |
| Kerala Ayurveda Limited | 155 Million INR | 44.763% |
| Cian Healthcare Limited | 409.27 Million INR | 79.081% |
| Trinity League India Limited | 24.76 Million INR | -245.704% |
| Syschem (India) Limited | 513.95 Million INR | 83.342% |
| KOBO BIOTECH LIMITED | 180.4 Million INR | 52.542% |
| Natural Capsules Limited | 190.35 Million INR | 55.023% |
| Auro Laboratories Limited | 82.39 Million INR | -3.908% |